Altris.AI – The New Era of Retinal Diagnosis is Coming

(Altris, Inc) announced it has signed an agreement with a South Korean
ophthalmic and optical medical equipment manufacturer Huvitz
Co., Ltd.
aimed at the development of customized deep learning
solutions for retinal diseases detection unique for Huvitz HOCT-1/1F
device, All-in-One PC integrated 3D Optical Coherence Tomography (OCT)
and Fundus Camera.

Altris.AI’s OCT and Fundus algorithms have been trained using anonymized
OCT retinal scans as well as Fundus images collected during more than 12
years, and are able to detect more than 50 retinal diseases and
conditions. Currently, Altris.AI’s solution is available in web and
mobile version for structural retina analysis. The model shows the high
level of performance with multi-disease classification accuracy more
than 96%.

The main retinal conditions which Altris.AI model can detect:

• Normal retina;

• Dry Age-Related Macular Degeneration;

• Wet Age-Related Macular Degeneration;

• Diabetic Retinopathy;

• Retinal Hemorrhage;

• Retinal Detachment;

• Central Serous Retinopathy;

• Macular Pucker (Epiretinal Fibrosis);

• Degenerative Myopia;

• Vitreo-Macular Traction Syndrome;

• Vitreous Detachment;

• Macular Hole;

• Lamellar Macular Hole;

• Pseudohole;

• Central Retinal Vein Occlusion;

• Branch Retinal Vein Occlusion;

• Retinal Artery Occlusion;

• Pigment Choroidal Nevus;

• Solar Maculopathy;

• Chorioretinal scars;

• Vitelliform Dystrophy;

• Tapetoretinal Dystrophy;

• Retinitis Pigmentosa.

Altris.AI’s technology will complement Huvitz All-in-One 3D OCT and
Fundus Camera device by adding new features for diagnostic support and
automatic retinal diseases detection on OCT scans or Fundus images in
combination or separately, which allows ophthalmologists and
optometrists with basic knowledge to have higher level of performance as
an experienced retinal imaging specialist in just couple of clicks.

About Altris.AI

Altris.AI (Altris, Inc) is a company which applies computer vision and
deep learning trained algorithms to build innovative ophthalmology
diagnosis real-time support platform for the automatic, structural and
quantitative analysis and detection of glaucoma, age-related macular
degeneration, diabetic retinopathy and other retinal diseases on Optical
Coherence Tomography (OCT) scans and Fundus images by learning from a
large dataset of clinical cases. The company accumulated and legally
owns one of the most massive anonymized databases of the retina, optic
nerve scans, and images as well as clinical data. We continue increasing
our dataset daily in our ophthalmology center with OCT, OCT-Angio scans
and Fundus images.

For more information, please visit http://altris.ai

Follow us on Facebook
and LinkedIn


For Altris.AI (Altris, Inc)
Andrey Kuropyatnyk
[email protected]


Content is the most important part of having quality links to your website. With Area-Info.net, we provide a quality location to share your story and include links to your website to help you grow. If you would like to learn more, visit this page to see how you can use Area-Info.net to rank higher and quicker in search engines. Contact me directly at [email protected] with any questions, or to schedule speaking engagements.